U.S. Medical Equipment Stock News

NYSE:MCK
NYSE:MCKHealthcare

Will McKesson’s (MCK) Strong Q4 Results and Massive Buybacks Recast Its Investment Narrative?

In early May 2026, McKesson reported fourth-quarter sales of US$96.30 billion and net income of US$1.68 billion, with full-year sales reaching US$403.43 billion and net income of US$4.76 billion, alongside robust earnings per share growth from continuing operations. At the same time, McKesson completed a very large share repurchase program totaling 66.50 million shares for US$21.13 billion, a move that aligns with institutional investors’ focus on its resilient pharmaceutical distribution...
NYSE:NVR
NYSE:NVRConsumer Durables

NVR’s New $750 Million Buyback and ESG Vote Might Change The Case For Investing In NVR (NVR)

NVR, Inc. in early May 2026 authorized a new share repurchase program of up to US$750,000,000 with no expiration, alongside routine equity option grants to directors and senior executives tied in part to future return on capital performance. The buyback authorization came shortly after shareholders declined to approve a proposal on greenhouse gas emissions disclosure, underscoring management’s current priorities around capital allocation and governance. We’ll now examine how NVR’s sizeable,...
NYSE:AA
NYSE:AAMetals and Mining

Is It Too Late To Consider Alcoa (AA) After A 129% One Year Surge?

Investors may be wondering whether Alcoa, at around US$64 a share, still offers value or if most of the opportunity has already been priced in. The stock is up 13.4% year to date and 128.6% over the past year, even though it has fallen 6.3% over the last week and 3.6% over the past month. These moves sit against a backdrop of ongoing attention on metals and mining companies, with investors weighing factors such as commodity demand, input costs and capital allocation decisions. Short term...
NYSE:COUR
NYSE:COURConsumer Services

Is Coursera’s US$500 Million Buyback Altering The Investment Case For Coursera (COUR)?

Earlier this month, Coursera’s board approved an open-ended share repurchase program of up to US$500,000,000, funded from existing cash and cash flow, following its completed merger with Udemy and recent increases in authorized common stock. This move, alongside fresh board appointments from Udemy and a new shelf registration for ESOP-related shares, signals a meaningful shift in how Coursera balances capital returns, governance, and employee ownership after the combination. Next, we’ll...
NasdaqGS:DXCM
NasdaqGS:DXCMMedical Equipment

DexCom Tests Wider Type 2 CGM Adoption With German Dexcom Flex Launch

DexCom (NasdaqGS:DXCM) has launched Dexcom Flex, a continuous glucose monitoring system for adults with Type 2 diabetes in Germany. The system is aimed at patients who are not on intensive insulin therapy, including those using basal insulin, oral medications or GLP-1 receptor agonists. This rollout extends DexCom's CGM offering to a broader segment of the Type 2 diabetes population that historically had limited CGM access. DexCom focuses on continuous glucose monitoring technology for...
NYSE:CMS
NYSE:CMSIntegrated Utilities

CMS Energy Refines Renewable Operations As Aviator Wind Taps New Manager

NorthStar Clean Energy's Aviator Wind project, a 525 MW single site wind facility, has appointed Consolidated Asset Management Services (CAMS) as its new asset management partner. CAMS will oversee operations, maintenance, and compliance for the Aviator Wind site, one of the largest single site wind projects in the U.S. The project is owned by NorthStar Clean Energy, a subsidiary of CMS Energy (NYSE:CMS). The change in asset manager represents a material operational shift for the...
NYSE:CWEN
NYSE:CWENRenewable Energy

Does Clearway’s Reaffirmed CAFD and US$3 Billion Pipeline Reshape The Bull Case For CWEN?

Clearway Energy, Inc. recently reported mixed first-quarter 2026 results, with sales rising to US$354 million but a net loss of US$163 million, reaffirmed its full-year cash available for distribution guidance and long-term targets, and outlined multi-year investment plans in wind repowering, storage and acquisitions. Ahead of a June 2026 leadership change in the General Counsel role, the company is emphasizing continuity in governance as it pursues growth tied to rising power demand,...
NasdaqGS:PAA
NasdaqGS:PAAOil and Gas

Why Plains All American Pipeline (PAA) Is Up 6.6% After Revenue Rose But Net Income Dropped

Plains All American Pipeline, L.P. has reported past first-quarter 2026 results, with revenue rising to US$12,470 million from US$11,477 million a year earlier, while net income fell to US$152 million from US$443 million. Although basic earnings per share from continuing operations were broadly steady, overall basic earnings per share dropped to US$0.14 from US$0.49, highlighting pressure on profitability despite higher revenue. Next, we will examine how higher revenue but weaker net income...
NasdaqGS:SHC
NasdaqGS:SHCLife Sciences

How Investors May Respond To Sotera Health (SHC) Raising $486 Million In Follow-On Equity

Earlier this month, Sotera Health completed a follow-on equity offering of 31,838,253 common shares at US$15.27 each, raising about US$486.17 million at a small discount to the offer price. This sizeable capital raise materially increases Sotera Health’s funding flexibility, potentially affecting how investors assess its balance sheet strength and future investment capacity. We’ll now examine how this sizable follow-on equity raise could reshape Sotera Health’s investment narrative and...
NasdaqGS:MCRI
NasdaqGS:MCRIHospitality

A Look At Monarch Casino & Resort (MCRI) Valuation After Earnings Beat And Reno Renovations

Monarch Casino & Resort (MCRI) is back in focus after a significant earnings beat and recent room renovations in Reno, a combination that helped push the stock to an all time high near US$120. See our latest analysis for Monarch Casino & Resort. That earnings surprise and the Reno refresh sit alongside a strong 30 day share price return of 17.18% and a 1 year total shareholder return of 45.24%. Together, these point to momentum building around the Monarch Casino & Resort story and changing...
NasdaqGS:URBN
NasdaqGS:URBNSpecialty Retail

Assessing Urban Outfitters (URBN) After Recent Share Price Swings And DCF Valuation Gap

Wondering if Urban Outfitters at US$71.67 is priced for opportunity or caution? This article walks through what that share price could mean for you as an investor. The stock is up 7.9% over the past week, while it is down 5.9% over the past month, down 4.9% year to date, and has returned 20.3% over the past year, 128.6% over three years, and 86.3% over five years. Recent coverage around Urban Outfitters has focused on its position within Specialty Retail and how investors are reacting to its...
NYSE:FMC
NYSE:FMCChemicals

Will FMC's (FMC) US$750 Million Secured Notes Shift Its Balance Sheet Repair Narrative

Earlier this week, FMC Corporation completed a fixed-income offering of US$750 million in senior secured notes due 2031, issued under Regulation S and Rule 144A with attached guarantees. This substantial bond raise strengthens FMC’s financial toolkit, potentially giving the company more flexibility to fund operations, address debt, or support future growth initiatives. Next, we’ll examine how FMC’s US$750 million senior secured notes could influence its investment narrative and balance-sheet...
NYSE:GBCI
NYSE:GBCIBanks

Glacier Bancorp (GBCI) Valuation Check As Shares Outpace Long Term Regional Bank Peers

With no single headline event driving attention to Glacier Bancorp (GBCI) today, the focus for investors is on the bank’s recent share performance and current valuation signals in a shifting regional banking backdrop. See our latest analysis for Glacier Bancorp. Glacier Bancorp’s recent 1-day share price return of 2.39% comes after a softer 30-day share price return, while the 1-year total shareholder return of 20.75% and 3-year total shareholder return of 79.18% point to longer term momentum...
NasdaqGS:ERAS
NasdaqGS:ERASBiotechs

Erasca Merck Pact Puts ERAS 0015 KEYTRUDA Combo In Investor Focus

Erasca (NasdaqGS:ERAS) entered a collaboration with Merck to study ERAS-0015 in combination with KEYTRUDA in RAS mutant solid tumors. The companies agreed a new clinical trial arrangement that will evaluate the combination regimen in late-stage settings. Erasca focuses on therapies that target the RAS pathway, an area of high interest across oncology research. KEYTRUDA is a widely used immuno-oncology therapy, so pairing it with ERAS-0015 places the company in a clinically and commercially...
NasdaqGM:WLDN
NasdaqGM:WLDNProfessional Services

How Strong Q1 Results and Higher 2026 Targets At Willdan Group (WLDN) Have Changed Its Investment Story

Willdan Group, Inc. recently reported first-quarter 2026 results, with sales of US$155.11 million and net income of US$8.53 million, alongside higher earnings per share than a year earlier. The company linked its improved quarterly performance to strong demand for its energy solutions and benefits from the Burton Energy Group acquisition, while also raising its 2026 financial targets and long-term margin goals. Next, we will examine how Willdan’s upgraded 2026 financial targets and margin...
NasdaqGS:CSGP
NasdaqGS:CSGPReal Estate

Is It Time To Reassess CoStar Group (CSGP) After This Year’s Sharp Share Price Slide

Wondering whether CoStar Group at around US$34.01 is starting to look like value or still has more room to fall or recover? This article breaks down what the current price might be implying about the stock. The stock has risen 6.4% over the last week, yet it remains down 15.1% over the last month and has declined 48.2% year to date and 54.0% over the past year, so recent trading has been choppy for long term holders. Recent coverage around CoStar Group has focused on how investors are...
NYSEAM:CMCL
NYSEAM:CMCLMetals and Mining

Is It Time To Revisit Caledonia Mining (CMCL) After The Recent Share Price Pullback?

If you are wondering whether Caledonia Mining stock is offering value at around US$22.96, it helps to line up the recent share price moves with what the business might be worth. The stock has pulled back recently, with the price declining about 7.2% over the past week and 12.2% over the past month, although the 1 year return of 35.9% and 3 year return of 100.4% paint a very different picture for longer term holders. Recent moves in the share price sit against a backdrop of ongoing interest...
NYSE:RDW
NYSE:RDWAerospace & Defense

Redwire’s NATO Drone Deal Adds Long Term Defense Revenue Visibility

Redwire (NYSE:RDW) has secured a high eight-figure, multi-year contract from a NATO ally for its Penguin Mk3 tactical uncrewed aerial system. The award covers next-generation Penguin Mk3 drone systems and long-term program support using Redwire's European infrastructure. The Penguin platform has operational experience in Ukraine, which supported the selection decision for this NATO contract. For you as an investor, this NATO order adds a concrete defense program to Redwire's existing space...
NYSE:SWK
NYSE:SWKMachinery

Stanley Black And Decker Toys Deal Aims At Future DIY Customers

Stanley Black & Decker (NYSE:SWK) has renewed and expanded its BLACK+DECKER toy licensing agreement with JAKKS Pacific. The multi year deal extends the partnership through 2028 across key North and South American markets. The agreement covers a broad range of toy product categories aimed at younger consumers. For a tools and hardware company such as Stanley Black & Decker, the BLACK+DECKER toy line is one way to keep the brand in front of future do it yourself customers. The renewed JAKKS...
NYSE:BMY
NYSE:BMYPharmaceuticals

A Look At Bristol Myers Squibb (BMY) Valuation After Recent Share Price Strength And Mixed Earnings Figures

Stock performance snapshot Bristol-Myers Squibb (BMY) has drawn fresh attention after a solid year-to-date total return of about 9.5%, alongside a 1-year total return near 30.8% and a current share price around US$58.54. See our latest analysis for Bristol-Myers Squibb. Recent moves show mixed momentum, with the 7-day share price return of 3.8% sitting against a 30-day share price decline of 1.0%. However, the 1-year total shareholder return of 30.8% points to a stronger longer term...
NasdaqGS:BZ
NasdaqGS:BZProfessional Services

Does Strong Q1 AI-Driven Profitability and Buybacks Change The Bull Case For Kanzhun (BZ)?

Kanzhun Limited has now reported its first-quarter 2026 results, with revenue rising to CNY 2,068.79 million and net income to CNY 1,156.69 million, alongside higher basic and diluted earnings per share. Beyond the headline figures, management pointed to rapid AI adoption and growth in paid enterprise customers and blue-collar recruitment as key drivers of the quarter’s performance. We’ll now examine how Kanzhun’s stronger profitability, supported by AI-driven recruitment and ongoing share...